Cargando…
Alantolactone inhibits cervical cancer progression by downregulating BMI1
Cervical cancer is the second most common cancer in women. Despite advances in cervical cancer therapy, tumor recurrence and metastasis remain the leading causes of mortality. High expression of BMI1 is significantly associated with poor tumor differentiation, high clinical grade, and poor prognosis...
Autores principales: | Sun, Xiaodong, Xu, Hongxia, Dai, Tianyu, Xie, Lixia, Zhao, Qiang, Hao, Xincai, Sun, Yan, Wang, Xuanbin, Jiang, Nan, Sang, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085045/ https://www.ncbi.nlm.nih.gov/pubmed/33927214 http://dx.doi.org/10.1038/s41598-021-87781-z |
Ejemplares similares
-
Hydroxypropyl-β-Cyclodextrin-Complexed Resveratrol Enhanced Antitumor Activity in a Cervical Cancer Model: In Vivo Analysis
por: Hao, Xincai, et al.
Publicado: (2021) -
Resveratrol suppresses the growth and metastatic potential of cervical cancer by inhibiting STAT3(Tyr705) phosphorylation
por: Sun, Xiaodong, et al.
Publicado: (2020) -
Resveratrol inhibits the progression of cervical cancer by suppressing the transcription and expression of HPV E6 and E7 genes
por: Sun, Xiaodong, et al.
Publicado: (2021) -
Triggering of Programmed Erythrocyte Death by Alantolactone
por: Alzoubi, Kousi, et al.
Publicado: (2014) -
Targeting Apoptosis Pathways in Cancer with Alantolactone and Isoalantolactone
por: Rasul, Azhar, et al.
Publicado: (2013)